Prognostic Implications of Body Composition Changes in Pancreatic Cancer Patients

733 patients with baseline CT scans and 595 with paired scans at 12 weeks were retrospectively analyzed. Jong Hyuk Lee published this dataset on figshare in March 2026. It examines changes in skeletal muscle index, visceral fat area, and subcutaneous fat index during chemotherapy treatment for non-metastatic pancreatic ductal adenocarcinoma.

Use Cases

• Predicting overall survival based on baseline visceral obesity metrics.
• Analyzing associations between skeletal muscle mass decline and disease progression.
• Investigating the prognostic value of subcutaneous fat changes during chemotherapy.
• Correlating body composition changes with patient outcomes following curative resection.

Strengths

• Includes 733 patient records with baseline CT scans.
• Contains longitudinal data for 595 patients with paired scans at baseline and 12 weeks.
• Quantifies multiple body composition metrics derived from CT scans.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Retrospective analysis of patients treated between January 2017 and December 2020.

Time Range

January 2017 to December 2020

Freshness

Last updated 2026-03-19 05:19:55; freshness should be verified.